Clinical Trial Update: Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating dose escalation to dominant intraprostatic lesions using MRI-TRUS fusion-guided HDR brachytherapy for prostate can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Alfonso Gomez-Iturriaga | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN